Disease-modifying therapies (DMTs) for multiple sclerosis (MS) have developed tremendously over the last 2 decades. Currently, more than 16 different products targeting various immunologic components have been approved for MS treatment in several countries.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...